10

May

2022

15:00

BST

16:00

CEST

Webinar

How Can I Simultaneously Optimize TAVI and Future Coronary Access? Lifetime Management of Patients With Severe AS Without Compromise

Overview

Coronary Artery Disease (CAD) is present in 60–70% of current TAVI patients1. Future TAVI patients will be treated at a younger age with longer life expectancy who may develop CAD. Therefore easy coronary access is paramount to treat current and future patient populations safely2.

This webinar aims to illustrate how to optimize procedural outcomes by using commissural alignment to preserve coronary access3,4 and increase options for possible future interventions.

 

Faculty:


Mohamed Abdel-Wahab

Mohamed Abdel-Wahab


Flavio Ribichini

Flavio Ribichini


Joanna J Wykrzykowska

Joanna J Wykrzykowska


Dr Rik van der Werf

Dr Rik van der Werf

This webinar is supported by:

Agenda

Welcome & Intro

Flavio Luciano Ribichini
16:00 - 16:02 CEST

Coronary access after TAVI: Why bother?

Mohamed Abdel-Wahab
16:02 - 16:12 CEST

Live Case Live from Groningen, Netherlands

Joanna Wykrzykowska
16:12 - 16:42 CEST

Faculty Discussion

All faculty
16:42 - 16:58 CEST

Summary

Mohammed Abdel-Wahab
16:58 - 17:00 CEST

Key Learning Objectives

  • Step by step demonstration how to perform commissural alignment
  • Understand current and predicted trends in TAVI with respect to preserving coronary access
  • Share experience and discuss lifetime management of patients with severe AS with consideration of factors for choosing valves in low risk populations

Target Audience

  • Interventional Cardiologists
  • Cardiac Surgeons
  • Interventional Fellows
  • TAVI Experts
  • Complex PCI experts

Faculty Biographies


Joanna J Wykrzykowska

Joanna J Wykrzykowska

View full profile

Dr Rik van der Werf

Dr Rik van der Werf

View full profile

Flavio Ribichini

Flavio Ribichini

Prof Flavio Ribichini is a board certificated Cardiologist at the University of Turin, the Director of the School of Cardiovascular Diseases of the School of Medicine University of Verona, and Clinical Director of the Division of Cardiology of AOUI, Verona.

Prof Ribichini is an interventionalist dedicated to vascular angioplaties, valvular replacement and congenital intervention.

View full profile

Mohamed Abdel-Wahab

Mohamed Abdel-Wahab

Internationally renowned interventional cardiologist specialized in TAVI and complex coronary interventions. Head of the department of structural heart disease at Heart Center Leipzig, the largest European center in terms of number of TAVI procedures. Professor Abdel-Wahab has contributed to over 200 papers in the field of interventional cardiology in high profile peer review journals.

View full profile

Key References

1. T. Lefèvre, A.P. Kappetein, E. Wolner, et al., PARTNER EY Investigator Group
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study

2. Short-and-Long-Term Outcomes after Coronary Rotational Atherectomy in Patients Treated with Trans-Catheter Aortic Valve Implantation.
Lunardi M, Pighi M, Venturi G, Del Sole PA, Pesarini G, Mainardi A, Scarsini R, Ferrero V, Gottin L, Ribichini F.
J Clin Med. 2020 Dec 31;10(1):112. doi: 10.3390/jcm10010112.
PMID: 33396185 Free PMC article.

3. Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves.
Bieliauskas G, Wong I, Bajoras V, Wang X, Kofoed KF, De Backer O, Søndergaard L.
JACC Cardiovasc Interv. 2021 Sep 8:S1936-8798(21)01233-4. doi: 10.1016/j.jcin.2021.06.033. Online ahead of print.
PMID: 34538602

4. Commissural Alignment of the ACURATE neo Valve in Transcatheter Aortic Valve Replacement.
Kitamura M, Wilde J, Gohmann R, Majunke N, Gutberlet M, Shibata M, Kiefer P, Desch S, Thiele H, Holzhey D, Abdel-Wahab M.
JACC Cardiovasc Interv. 2021 Aug 9;14(15):1740-1742. doi: 10.1016/j.jcin.2021.05.037.
PMID: 34353607 No abstract available.